It remains unclear whether IBD development is primarily improved by APOA4 directly fortifying mucosal integrity and dampening local inflammation, or by indirectly reducing systemic inflammation via enhanced FA oxidation and thermogenesis. Here, APOA4 is linked to irritable bowel syndrome.